Ellen S. Vitetta
18Patents
10h-index
11Co-inventors
69Inventor score
Filing activity: May 27, 1983 → May 2, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5686072A | Epitope-specific monoclonal antibodies and immunotoxins and uses thereof | Human Necessities | 196 | Expired |
| US6368596B1 | Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells | Chemistry; Metallurgy | 78 | Expired |
| US4664911A | Immunotoxin conjugates employing toxin B chain moieties | Emerging Cross-Sectional Technologies | 77 | Expired |
| US5045451A | Methods for screening antibodies for use as immunotoxins | Emerging Cross-Sectional Technologies | 74 | Expired |
| US4792447A | Anti-immunoglobulin toxin conjugates useful in the treatment of B cell tumors | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6566500B1 | Compositions and methods for modifying toxic effects of proteinaceous compounds | Chemistry; Metallurgy | 16 | Expired |
| US5612185A | Method for identifying tumor cells in cell cycle arrest | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7133725B2 | Method and related composition employing nanostructures | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7452971B2 | Compositions and methods for modifying toxic effects of proteinaceous compounds | Chemistry; Metallurgy | 12 | Expired |
| US5578706A | Methods and compositions concerning homogenous immunotoxin preparations | Human Necessities | 10 | Expired |
| US5767072A | Therapeutic compositions comprising a CD4 peptide and methods of treatment of HIV infections | Human Necessities | 9 | Expired |
| US8658168B2 | Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells | Chemistry; Metallurgy | 7 | Active |
| US9770504B2 | Generating peptoid vaccines | Emerging Cross-Sectional Technologies | 5 | Active |
| US7829668B2 | Compositions and methods for modifying toxic effects of proteinaceous compounds | Chemistry; Metallurgy | 5 | Active |
| US6960652B2 | Compositions and methods for modifying toxic effects of proteinaceous compounds | Chemistry; Metallurgy | 5 | Expired |
| US7668603B2 | Medical composition employing nanostructures | Emerging Cross-Sectional Technologies | 4 | Active |
| US7175848B1 | Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin | Human Necessities | 0 | Expired |
| US8323665B2 | Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.